Global Passive Transdermal Drug Delivery Market Growth 2022-2028
The report requires updating with new data and is sent in 48 hours after order is placed.
As the global economy mends, the 2021 growth of Passive Transdermal Drug Delivery will have significant change from previous year. According to our (LP Information) latest study, the global Passive Transdermal Drug Delivery market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Passive Transdermal Drug Delivery market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.
The United States Passive Transdermal Drug Delivery market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Passive Transdermal Drug Delivery market, reaching US$ million by the year 2028. As for the Europe Passive Transdermal Drug Delivery landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Passive Transdermal Drug Delivery players cover 3M, Actavis, Inc., Bayer AG, and Boehringer Ingelheim GmbH, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Passive Transdermal Drug Delivery market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
As the global economy mends, the 2021 growth of Passive Transdermal Drug Delivery will have significant change from previous year. According to our (LP Information) latest study, the global Passive Transdermal Drug Delivery market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Passive Transdermal Drug Delivery market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.
The United States Passive Transdermal Drug Delivery market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Passive Transdermal Drug Delivery market, reaching US$ million by the year 2028. As for the Europe Passive Transdermal Drug Delivery landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Passive Transdermal Drug Delivery players cover 3M, Actavis, Inc., Bayer AG, and Boehringer Ingelheim GmbH, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Passive Transdermal Drug Delivery market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
- Microfluidics
- Smart Pill Technology (SPT)
- Clinic
- Hospital
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- 3M
- Actavis, Inc.
- Bayer AG
- Boehringer Ingelheim GmbH
- Corium International, Inc.
- Echo Therapeutics, Inc.
- GlaxoSmithKline plc
- Johnson & Johnson (Janssen Pharmaceuticals Inc.)
- Mylan N.V.
- Novartis AG
- Noven Pharmaceuticals, Inc.
- Transdermal Corp.
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Passive Transdermal Drug Delivery Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Passive Transdermal Drug Delivery by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Passive Transdermal Drug Delivery by Country/Region, 2017, 2022 & 2028
2.2 Passive Transdermal Drug Delivery Segment by Type
2.2.1 Microfluidics
2.2.2 Smart Pill Technology (SPT)
2.3 Passive Transdermal Drug Delivery Sales by Type
2.3.1 Global Passive Transdermal Drug Delivery Sales Market Share by Type (2017-2022)
2.3.2 Global Passive Transdermal Drug Delivery Revenue and Market Share by Type (2017-2022)
2.3.3 Global Passive Transdermal Drug Delivery Sale Price by Type (2017-2022)
2.4 Passive Transdermal Drug Delivery Segment by Application
2.4.1 Clinic
2.4.2 Hospital
2.4.3 Others
2.5 Passive Transdermal Drug Delivery Sales by Application
2.5.1 Global Passive Transdermal Drug Delivery Sale Market Share by Application (2017-2022)
2.5.2 Global Passive Transdermal Drug Delivery Revenue and Market Share by Application (2017-2022)
2.5.3 Global Passive Transdermal Drug Delivery Sale Price by Application (2017-2022)
3 GLOBAL PASSIVE TRANSDERMAL DRUG DELIVERY BY COMPANY
3.1 Global Passive Transdermal Drug Delivery Breakdown Data by Company
3.1.1 Global Passive Transdermal Drug Delivery Annual Sales by Company (2020-2022)
3.1.2 Global Passive Transdermal Drug Delivery Sales Market Share by Company (2020-2022)
3.2 Global Passive Transdermal Drug Delivery Annual Revenue by Company (2020-2022)
3.2.1 Global Passive Transdermal Drug Delivery Revenue by Company (2020-2022)
3.2.2 Global Passive Transdermal Drug Delivery Revenue Market Share by Company (2020-2022)
3.3 Global Passive Transdermal Drug Delivery Sale Price by Company
3.4 Key Manufacturers Passive Transdermal Drug Delivery Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Passive Transdermal Drug Delivery Product Location Distribution
3.4.2 Players Passive Transdermal Drug Delivery Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR PASSIVE TRANSDERMAL DRUG DELIVERY BY GEOGRAPHIC REGION
4.1 World Historic Passive Transdermal Drug Delivery Market Size by Geographic Region (2017-2022)
4.1.1 Global Passive Transdermal Drug Delivery Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Passive Transdermal Drug Delivery Annual Revenue by Geographic Region
4.2 World Historic Passive Transdermal Drug Delivery Market Size by Country/Region (2017-2022)
4.2.1 Global Passive Transdermal Drug Delivery Annual Sales by Country/Region (2017-2022)
4.2.2 Global Passive Transdermal Drug Delivery Annual Revenue by Country/Region
4.3 Americas Passive Transdermal Drug Delivery Sales Growth
4.4 APAC Passive Transdermal Drug Delivery Sales Growth
4.5 Europe Passive Transdermal Drug Delivery Sales Growth
4.6 Middle East & Africa Passive Transdermal Drug Delivery Sales Growth
5 AMERICAS
5.1 Americas Passive Transdermal Drug Delivery Sales by Country
5.1.1 Americas Passive Transdermal Drug Delivery Sales by Country (2017-2022)
5.1.2 Americas Passive Transdermal Drug Delivery Revenue by Country (2017-2022)
5.2 Americas Passive Transdermal Drug Delivery Sales by Type
5.3 Americas Passive Transdermal Drug Delivery Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Passive Transdermal Drug Delivery Sales by Region
6.1.1 APAC Passive Transdermal Drug Delivery Sales by Region (2017-2022)
6.1.2 APAC Passive Transdermal Drug Delivery Revenue by Region (2017-2022)
6.2 APAC Passive Transdermal Drug Delivery Sales by Type
6.3 APAC Passive Transdermal Drug Delivery Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Passive Transdermal Drug Delivery by Country
7.1.1 Europe Passive Transdermal Drug Delivery Sales by Country (2017-2022)
7.1.2 Europe Passive Transdermal Drug Delivery Revenue by Country (2017-2022)
7.2 Europe Passive Transdermal Drug Delivery Sales by Type
7.3 Europe Passive Transdermal Drug Delivery Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Passive Transdermal Drug Delivery by Country
8.1.1 Middle East & Africa Passive Transdermal Drug Delivery Sales by Country (2017-2022)
8.1.2 Middle East & Africa Passive Transdermal Drug Delivery Revenue by Country (2017-2022)
8.2 Middle East & Africa Passive Transdermal Drug Delivery Sales by Type
8.3 Middle East & Africa Passive Transdermal Drug Delivery Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Passive Transdermal Drug Delivery
10.3 Manufacturing Process Analysis of Passive Transdermal Drug Delivery
10.4 Industry Chain Structure of Passive Transdermal Drug Delivery
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Passive Transdermal Drug Delivery Distributors
11.3 Passive Transdermal Drug Delivery Customer
12 WORLD FORECAST REVIEW FOR PASSIVE TRANSDERMAL DRUG DELIVERY BY GEOGRAPHIC REGION
12.1 Global Passive Transdermal Drug Delivery Market Size Forecast by Region
12.1.1 Global Passive Transdermal Drug Delivery Forecast by Region (2023-2028)
12.1.2 Global Passive Transdermal Drug Delivery Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Passive Transdermal Drug Delivery Forecast by Type
12.7 Global Passive Transdermal Drug Delivery Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 3M
13.1.1 3M Company Information
13.1.2 3M Passive Transdermal Drug Delivery Product Offered
13.1.3 3M Passive Transdermal Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 3M Main Business Overview
13.1.5 3M Latest Developments
13.2 Actavis, Inc.
13.2.1 Actavis, Inc. Company Information
13.2.2 Actavis, Inc. Passive Transdermal Drug Delivery Product Offered
13.2.3 Actavis, Inc. Passive Transdermal Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Actavis, Inc. Main Business Overview
13.2.5 Actavis, Inc. Latest Developments
13.3 Bayer AG
13.3.1 Bayer AG Company Information
13.3.2 Bayer AG Passive Transdermal Drug Delivery Product Offered
13.3.3 Bayer AG Passive Transdermal Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Bayer AG Main Business Overview
13.3.5 Bayer AG Latest Developments
13.4 Boehringer Ingelheim GmbH
13.4.1 Boehringer Ingelheim GmbH Company Information
13.4.2 Boehringer Ingelheim GmbH Passive Transdermal Drug Delivery Product Offered
13.4.3 Boehringer Ingelheim GmbH Passive Transdermal Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Boehringer Ingelheim GmbH Main Business Overview
13.4.5 Boehringer Ingelheim GmbH Latest Developments
13.5 Corium International, Inc.
13.5.1 Corium International, Inc. Company Information
13.5.2 Corium International, Inc. Passive Transdermal Drug Delivery Product Offered
13.5.3 Corium International, Inc. Passive Transdermal Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Corium International, Inc. Main Business Overview
13.5.5 Corium International, Inc. Latest Developments
13.6 Echo Therapeutics, Inc.
13.6.1 Echo Therapeutics, Inc. Company Information
13.6.2 Echo Therapeutics, Inc. Passive Transdermal Drug Delivery Product Offered
13.6.3 Echo Therapeutics, Inc. Passive Transdermal Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Echo Therapeutics, Inc. Main Business Overview
13.6.5 Echo Therapeutics, Inc. Latest Developments
13.7 GlaxoSmithKline plc
13.7.1 GlaxoSmithKline plc Company Information
13.7.2 GlaxoSmithKline plc Passive Transdermal Drug Delivery Product Offered
13.7.3 GlaxoSmithKline plc Passive Transdermal Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 GlaxoSmithKline plc Main Business Overview
13.7.5 GlaxoSmithKline plc Latest Developments
13.8 Johnson & Johnson (Janssen Pharmaceuticals Inc.)
13.8.1 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Company Information
13.8.2 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Passive Transdermal Drug Delivery Product Offered
13.8.3 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Passive Transdermal Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Main Business Overview
13.8.5 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Latest Developments
13.9 Mylan N.V.
13.9.1 Mylan N.V. Company Information
13.9.2 Mylan N.V. Passive Transdermal Drug Delivery Product Offered
13.9.3 Mylan N.V. Passive Transdermal Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Mylan N.V. Main Business Overview
13.9.5 Mylan N.V. Latest Developments
13.10 Novartis AG
13.10.1 Novartis AG Company Information
13.10.2 Novartis AG Passive Transdermal Drug Delivery Product Offered
13.10.3 Novartis AG Passive Transdermal Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Novartis AG Main Business Overview
13.10.5 Novartis AG Latest Developments
13.11 Noven Pharmaceuticals, Inc.
13.11.1 Noven Pharmaceuticals, Inc. Company Information
13.11.2 Noven Pharmaceuticals, Inc. Passive Transdermal Drug Delivery Product Offered
13.11.3 Noven Pharmaceuticals, Inc. Passive Transdermal Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Noven Pharmaceuticals, Inc. Main Business Overview
13.11.5 Noven Pharmaceuticals, Inc. Latest Developments
13.12 Transdermal Corp.
13.12.1 Transdermal Corp. Company Information
13.12.2 Transdermal Corp. Passive Transdermal Drug Delivery Product Offered
13.12.3 Transdermal Corp. Passive Transdermal Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Transdermal Corp. Main Business Overview
13.12.5 Transdermal Corp. Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Passive Transdermal Drug Delivery Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Passive Transdermal Drug Delivery by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Passive Transdermal Drug Delivery by Country/Region, 2017, 2022 & 2028
2.2 Passive Transdermal Drug Delivery Segment by Type
2.2.1 Microfluidics
2.2.2 Smart Pill Technology (SPT)
2.3 Passive Transdermal Drug Delivery Sales by Type
2.3.1 Global Passive Transdermal Drug Delivery Sales Market Share by Type (2017-2022)
2.3.2 Global Passive Transdermal Drug Delivery Revenue and Market Share by Type (2017-2022)
2.3.3 Global Passive Transdermal Drug Delivery Sale Price by Type (2017-2022)
2.4 Passive Transdermal Drug Delivery Segment by Application
2.4.1 Clinic
2.4.2 Hospital
2.4.3 Others
2.5 Passive Transdermal Drug Delivery Sales by Application
2.5.1 Global Passive Transdermal Drug Delivery Sale Market Share by Application (2017-2022)
2.5.2 Global Passive Transdermal Drug Delivery Revenue and Market Share by Application (2017-2022)
2.5.3 Global Passive Transdermal Drug Delivery Sale Price by Application (2017-2022)
3 GLOBAL PASSIVE TRANSDERMAL DRUG DELIVERY BY COMPANY
3.1 Global Passive Transdermal Drug Delivery Breakdown Data by Company
3.1.1 Global Passive Transdermal Drug Delivery Annual Sales by Company (2020-2022)
3.1.2 Global Passive Transdermal Drug Delivery Sales Market Share by Company (2020-2022)
3.2 Global Passive Transdermal Drug Delivery Annual Revenue by Company (2020-2022)
3.2.1 Global Passive Transdermal Drug Delivery Revenue by Company (2020-2022)
3.2.2 Global Passive Transdermal Drug Delivery Revenue Market Share by Company (2020-2022)
3.3 Global Passive Transdermal Drug Delivery Sale Price by Company
3.4 Key Manufacturers Passive Transdermal Drug Delivery Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Passive Transdermal Drug Delivery Product Location Distribution
3.4.2 Players Passive Transdermal Drug Delivery Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR PASSIVE TRANSDERMAL DRUG DELIVERY BY GEOGRAPHIC REGION
4.1 World Historic Passive Transdermal Drug Delivery Market Size by Geographic Region (2017-2022)
4.1.1 Global Passive Transdermal Drug Delivery Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Passive Transdermal Drug Delivery Annual Revenue by Geographic Region
4.2 World Historic Passive Transdermal Drug Delivery Market Size by Country/Region (2017-2022)
4.2.1 Global Passive Transdermal Drug Delivery Annual Sales by Country/Region (2017-2022)
4.2.2 Global Passive Transdermal Drug Delivery Annual Revenue by Country/Region
4.3 Americas Passive Transdermal Drug Delivery Sales Growth
4.4 APAC Passive Transdermal Drug Delivery Sales Growth
4.5 Europe Passive Transdermal Drug Delivery Sales Growth
4.6 Middle East & Africa Passive Transdermal Drug Delivery Sales Growth
5 AMERICAS
5.1 Americas Passive Transdermal Drug Delivery Sales by Country
5.1.1 Americas Passive Transdermal Drug Delivery Sales by Country (2017-2022)
5.1.2 Americas Passive Transdermal Drug Delivery Revenue by Country (2017-2022)
5.2 Americas Passive Transdermal Drug Delivery Sales by Type
5.3 Americas Passive Transdermal Drug Delivery Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Passive Transdermal Drug Delivery Sales by Region
6.1.1 APAC Passive Transdermal Drug Delivery Sales by Region (2017-2022)
6.1.2 APAC Passive Transdermal Drug Delivery Revenue by Region (2017-2022)
6.2 APAC Passive Transdermal Drug Delivery Sales by Type
6.3 APAC Passive Transdermal Drug Delivery Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Passive Transdermal Drug Delivery by Country
7.1.1 Europe Passive Transdermal Drug Delivery Sales by Country (2017-2022)
7.1.2 Europe Passive Transdermal Drug Delivery Revenue by Country (2017-2022)
7.2 Europe Passive Transdermal Drug Delivery Sales by Type
7.3 Europe Passive Transdermal Drug Delivery Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Passive Transdermal Drug Delivery by Country
8.1.1 Middle East & Africa Passive Transdermal Drug Delivery Sales by Country (2017-2022)
8.1.2 Middle East & Africa Passive Transdermal Drug Delivery Revenue by Country (2017-2022)
8.2 Middle East & Africa Passive Transdermal Drug Delivery Sales by Type
8.3 Middle East & Africa Passive Transdermal Drug Delivery Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Passive Transdermal Drug Delivery
10.3 Manufacturing Process Analysis of Passive Transdermal Drug Delivery
10.4 Industry Chain Structure of Passive Transdermal Drug Delivery
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Passive Transdermal Drug Delivery Distributors
11.3 Passive Transdermal Drug Delivery Customer
12 WORLD FORECAST REVIEW FOR PASSIVE TRANSDERMAL DRUG DELIVERY BY GEOGRAPHIC REGION
12.1 Global Passive Transdermal Drug Delivery Market Size Forecast by Region
12.1.1 Global Passive Transdermal Drug Delivery Forecast by Region (2023-2028)
12.1.2 Global Passive Transdermal Drug Delivery Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Passive Transdermal Drug Delivery Forecast by Type
12.7 Global Passive Transdermal Drug Delivery Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 3M
13.1.1 3M Company Information
13.1.2 3M Passive Transdermal Drug Delivery Product Offered
13.1.3 3M Passive Transdermal Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 3M Main Business Overview
13.1.5 3M Latest Developments
13.2 Actavis, Inc.
13.2.1 Actavis, Inc. Company Information
13.2.2 Actavis, Inc. Passive Transdermal Drug Delivery Product Offered
13.2.3 Actavis, Inc. Passive Transdermal Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Actavis, Inc. Main Business Overview
13.2.5 Actavis, Inc. Latest Developments
13.3 Bayer AG
13.3.1 Bayer AG Company Information
13.3.2 Bayer AG Passive Transdermal Drug Delivery Product Offered
13.3.3 Bayer AG Passive Transdermal Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Bayer AG Main Business Overview
13.3.5 Bayer AG Latest Developments
13.4 Boehringer Ingelheim GmbH
13.4.1 Boehringer Ingelheim GmbH Company Information
13.4.2 Boehringer Ingelheim GmbH Passive Transdermal Drug Delivery Product Offered
13.4.3 Boehringer Ingelheim GmbH Passive Transdermal Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Boehringer Ingelheim GmbH Main Business Overview
13.4.5 Boehringer Ingelheim GmbH Latest Developments
13.5 Corium International, Inc.
13.5.1 Corium International, Inc. Company Information
13.5.2 Corium International, Inc. Passive Transdermal Drug Delivery Product Offered
13.5.3 Corium International, Inc. Passive Transdermal Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Corium International, Inc. Main Business Overview
13.5.5 Corium International, Inc. Latest Developments
13.6 Echo Therapeutics, Inc.
13.6.1 Echo Therapeutics, Inc. Company Information
13.6.2 Echo Therapeutics, Inc. Passive Transdermal Drug Delivery Product Offered
13.6.3 Echo Therapeutics, Inc. Passive Transdermal Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Echo Therapeutics, Inc. Main Business Overview
13.6.5 Echo Therapeutics, Inc. Latest Developments
13.7 GlaxoSmithKline plc
13.7.1 GlaxoSmithKline plc Company Information
13.7.2 GlaxoSmithKline plc Passive Transdermal Drug Delivery Product Offered
13.7.3 GlaxoSmithKline plc Passive Transdermal Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 GlaxoSmithKline plc Main Business Overview
13.7.5 GlaxoSmithKline plc Latest Developments
13.8 Johnson & Johnson (Janssen Pharmaceuticals Inc.)
13.8.1 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Company Information
13.8.2 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Passive Transdermal Drug Delivery Product Offered
13.8.3 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Passive Transdermal Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Main Business Overview
13.8.5 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Latest Developments
13.9 Mylan N.V.
13.9.1 Mylan N.V. Company Information
13.9.2 Mylan N.V. Passive Transdermal Drug Delivery Product Offered
13.9.3 Mylan N.V. Passive Transdermal Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Mylan N.V. Main Business Overview
13.9.5 Mylan N.V. Latest Developments
13.10 Novartis AG
13.10.1 Novartis AG Company Information
13.10.2 Novartis AG Passive Transdermal Drug Delivery Product Offered
13.10.3 Novartis AG Passive Transdermal Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Novartis AG Main Business Overview
13.10.5 Novartis AG Latest Developments
13.11 Noven Pharmaceuticals, Inc.
13.11.1 Noven Pharmaceuticals, Inc. Company Information
13.11.2 Noven Pharmaceuticals, Inc. Passive Transdermal Drug Delivery Product Offered
13.11.3 Noven Pharmaceuticals, Inc. Passive Transdermal Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Noven Pharmaceuticals, Inc. Main Business Overview
13.11.5 Noven Pharmaceuticals, Inc. Latest Developments
13.12 Transdermal Corp.
13.12.1 Transdermal Corp. Company Information
13.12.2 Transdermal Corp. Passive Transdermal Drug Delivery Product Offered
13.12.3 Transdermal Corp. Passive Transdermal Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Transdermal Corp. Main Business Overview
13.12.5 Transdermal Corp. Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Passive Transdermal Drug Delivery Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Passive Transdermal Drug Delivery Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Microfluidics
Table 4. Major Players of Smart Pill Technology (SPT)
Table 5. Global Passive Transdermal Drug Delivery Sales by Type (2017-2022) & (K Units)
Table 6. Global Passive Transdermal Drug Delivery Sales Market Share by Type (2017-2022)
Table 7. Global Passive Transdermal Drug Delivery Revenue by Type (2017-2022) & ($ million)
Table 8. Global Passive Transdermal Drug Delivery Revenue Market Share by Type (2017-2022)
Table 9. Global Passive Transdermal Drug Delivery Sale Price by Type (2017-2022) & (USD/Unit)
Table 10. Global Passive Transdermal Drug Delivery Sales by Application (2017-2022) & (K Units)
Table 11. Global Passive Transdermal Drug Delivery Sales Market Share by Application (2017-2022)
Table 12. Global Passive Transdermal Drug Delivery Revenue by Application (2017-2022)
Table 13. Global Passive Transdermal Drug Delivery Revenue Market Share by Application (2017-2022)
Table 14. Global Passive Transdermal Drug Delivery Sale Price by Application (2017-2022) & (USD/Unit)
Table 15. Global Passive Transdermal Drug Delivery Sales by Company (2020-2022) & (K Units)
Table 16. Global Passive Transdermal Drug Delivery Sales Market Share by Company (2020-2022)
Table 17. Global Passive Transdermal Drug Delivery Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Passive Transdermal Drug Delivery Revenue Market Share by Company (2020-2022)
Table 19. Global Passive Transdermal Drug Delivery Sale Price by Company (2020-2022) & (USD/Unit)
Table 20. Key Manufacturers Passive Transdermal Drug Delivery Producing Area Distribution and Sales Area
Table 21. Players Passive Transdermal Drug Delivery Products Offered
Table 22. Passive Transdermal Drug Delivery Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Passive Transdermal Drug Delivery Sales by Geographic Region (2017-2022) & (K Units)
Table 26. Global Passive Transdermal Drug Delivery Sales Market Share Geographic Region (2017-2022)
Table 27. Global Passive Transdermal Drug Delivery Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Passive Transdermal Drug Delivery Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Passive Transdermal Drug Delivery Sales by Country/Region (2017-2022) & (K Units)
Table 30. Global Passive Transdermal Drug Delivery Sales Market Share by Country/Region (2017-2022)
Table 31. Global Passive Transdermal Drug Delivery Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Passive Transdermal Drug Delivery Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Passive Transdermal Drug Delivery Sales by Country (2017-2022) & (K Units)
Table 34. Americas Passive Transdermal Drug Delivery Sales Market Share by Country (2017-2022)
Table 35. Americas Passive Transdermal Drug Delivery Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Passive Transdermal Drug Delivery Revenue Market Share by Country (2017-2022)
Table 37. Americas Passive Transdermal Drug Delivery Sales by Type (2017-2022) & (K Units)
Table 38. Americas Passive Transdermal Drug Delivery Sales Market Share by Type (2017-2022)
Table 39. Americas Passive Transdermal Drug Delivery Sales by Application (2017-2022) & (K Units)
Table 40. Americas Passive Transdermal Drug Delivery Sales Market Share by Application (2017-2022)
Table 41. APAC Passive Transdermal Drug Delivery Sales by Region (2017-2022) & (K Units)
Table 42. APAC Passive Transdermal Drug Delivery Sales Market Share by Region (2017-2022)
Table 43. APAC Passive Transdermal Drug Delivery Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Passive Transdermal Drug Delivery Revenue Market Share by Region (2017-2022)
Table 45. APAC Passive Transdermal Drug Delivery Sales by Type (2017-2022) & (K Units)
Table 46. APAC Passive Transdermal Drug Delivery Sales Market Share by Type (2017-2022)
Table 47. APAC Passive Transdermal Drug Delivery Sales by Application (2017-2022) & (K Units)
Table 48. APAC Passive Transdermal Drug Delivery Sales Market Share by Application (2017-2022)
Table 49. Europe Passive Transdermal Drug Delivery Sales by Country (2017-2022) & (K Units)
Table 50. Europe Passive Transdermal Drug Delivery Sales Market Share by Country (2017-2022)
Table 51. Europe Passive Transdermal Drug Delivery Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Passive Transdermal Drug Delivery Revenue Market Share by Country (2017-2022)
Table 53. Europe Passive Transdermal Drug Delivery Sales by Type (2017-2022) & (K Units)
Table 54. Europe Passive Transdermal Drug Delivery Sales Market Share by Type (2017-2022)
Table 55. Europe Passive Transdermal Drug Delivery Sales by Application (2017-2022) & (K Units)
Table 56. Europe Passive Transdermal Drug Delivery Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Passive Transdermal Drug Delivery Sales by Country (2017-2022) & (K Units)
Table 58. Middle East & Africa Passive Transdermal Drug Delivery Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Passive Transdermal Drug Delivery Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Passive Transdermal Drug Delivery Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Passive Transdermal Drug Delivery Sales by Type (2017-2022) & (K Units)
Table 62. Middle East & Africa Passive Transdermal Drug Delivery Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Passive Transdermal Drug Delivery Sales by Application (2017-2022) & (K Units)
Table 64. Middle East & Africa Passive Transdermal Drug Delivery Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Passive Transdermal Drug Delivery
Table 66. Key Market Challenges & Risks of Passive Transdermal Drug Delivery
Table 67. Key Industry Trends of Passive Transdermal Drug Delivery
Table 68. Passive Transdermal Drug Delivery Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Passive Transdermal Drug Delivery Distributors List
Table 71. Passive Transdermal Drug Delivery Customer List
Table 72. Global Passive Transdermal Drug Delivery Sales Forecast by Region (2023-2028) & (K Units)
Table 73. Global Passive Transdermal Drug Delivery Sales Market Forecast by Region
Table 74. Global Passive Transdermal Drug Delivery Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Passive Transdermal Drug Delivery Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Passive Transdermal Drug Delivery Sales Forecast by Country (2023-2028) & (K Units)
Table 77. Americas Passive Transdermal Drug Delivery Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Passive Transdermal Drug Delivery Sales Forecast by Region (2023-2028) & (K Units)
Table 79. APAC Passive Transdermal Drug Delivery Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Passive Transdermal Drug Delivery Sales Forecast by Country (2023-2028) & (K Units)
Table 81. Europe Passive Transdermal Drug Delivery Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Passive Transdermal Drug Delivery Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Middle East & Africa Passive Transdermal Drug Delivery Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Passive Transdermal Drug Delivery Sales Forecast by Type (2023-2028) & (K Units)
Table 85. Global Passive Transdermal Drug Delivery Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Passive Transdermal Drug Delivery Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Passive Transdermal Drug Delivery Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Passive Transdermal Drug Delivery Sales Forecast by Application (2023-2028) & (K Units)
Table 89. Global Passive Transdermal Drug Delivery Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Passive Transdermal Drug Delivery Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Passive Transdermal Drug Delivery Revenue Market Share Forecast by Application (2023-2028)
Table 92. 3M Basic Information, Passive Transdermal Drug Delivery Manufacturing Base, Sales Area and Its Competitors
Table 93. 3M Passive Transdermal Drug Delivery Product Offered
Table 94. 3M Passive Transdermal Drug Delivery Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 95. 3M Main Business
Table 96. 3M Latest Developments
Table 97. Actavis, Inc. Basic Information, Passive Transdermal Drug Delivery Manufacturing Base, Sales Area and Its Competitors
Table 98. Actavis, Inc. Passive Transdermal Drug Delivery Product Offered
Table 99. Actavis, Inc. Passive Transdermal Drug Delivery Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 100. Actavis, Inc. Main Business
Table 101. Actavis, Inc. Latest Developments
Table 102. Bayer AG Basic Information, Passive Transdermal Drug Delivery Manufacturing Base, Sales Area and Its Competitors
Table 103. Bayer AG Passive Transdermal Drug Delivery Product Offered
Table 104. Bayer AG Passive Transdermal Drug Delivery Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 105. Bayer AG Main Business
Table 106. Bayer AG Latest Developments
Table 107. Boehringer Ingelheim GmbH Basic Information, Passive Transdermal Drug Delivery Manufacturing Base, Sales Area and Its Competitors
Table 108. Boehringer Ingelheim GmbH Passive Transdermal Drug Delivery Product Offered
Table 109. Boehringer Ingelheim GmbH Passive Transdermal Drug Delivery Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 110. Boehringer Ingelheim GmbH Main Business
Table 111. Boehringer Ingelheim GmbH Latest Developments
Table 112. Corium International, Inc. Basic Information, Passive Transdermal Drug Delivery Manufacturing Base, Sales Area and Its Competitors
Table 113. Corium International, Inc. Passive Transdermal Drug Delivery Product Offered
Table 114. Corium International, Inc. Passive Transdermal Drug Delivery Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 115. Corium International, Inc. Main Business
Table 116. Corium International, Inc. Latest Developments
Table 117. Echo Therapeutics, Inc. Basic Information, Passive Transdermal Drug Delivery Manufacturing Base, Sales Area and Its Competitors
Table 118. Echo Therapeutics, Inc. Passive Transdermal Drug Delivery Product Offered
Table 119. Echo Therapeutics, Inc. Passive Transdermal Drug Delivery Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 120. Echo Therapeutics, Inc. Main Business
Table 121. Echo Therapeutics, Inc. Latest Developments
Table 122. GlaxoSmithKline plc Basic Information, Passive Transdermal Drug Delivery Manufacturing Base, Sales Area and Its Competitors
Table 123. GlaxoSmithKline plc Passive Transdermal Drug Delivery Product Offered
Table 124. GlaxoSmithKline plc Passive Transdermal Drug Delivery Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 125. GlaxoSmithKline plc Main Business
Table 126. GlaxoSmithKline plc Latest Developments
Table 127. Johnson & Johnson (Janssen Pharmaceuticals Inc.) Basic Information, Passive Transdermal Drug Delivery Manufacturing Base, Sales Area and Its Competitors
Table 128. Johnson & Johnson (Janssen Pharmaceuticals Inc.) Passive Transdermal Drug Delivery Product Offered
Table 129. Johnson & Johnson (Janssen Pharmaceuticals Inc.) Passive Transdermal Drug Delivery Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 130. Johnson & Johnson (Janssen Pharmaceuticals Inc.) Main Business
Table 131. Johnson & Johnson (Janssen Pharmaceuticals Inc.) Latest Developments
Table 132. Mylan N.V. Basic Information, Passive Transdermal Drug Delivery Manufacturing Base, Sales Area and Its Competitors
Table 133. Mylan N.V. Passive Transdermal Drug Delivery Product Offered
Table 134. Mylan N.V. Passive Transdermal Drug Delivery Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 135. Mylan N.V. Main Business
Table 136. Mylan N.V. Latest Developments
Table 137. Novartis AG Basic Information, Passive Transdermal Drug Delivery Manufacturing Base, Sales Area and Its Competitors
Table 138. Novartis AG Passive Transdermal Drug Delivery Product Offered
Table 139. Novartis AG Passive Transdermal Drug Delivery Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 140. Novartis AG Main Business
Table 141. Novartis AG Latest Developments
Table 142. Noven Pharmaceuticals, Inc. Basic Information, Passive Transdermal Drug Delivery Manufacturing Base, Sales Area and Its Competitors
Table 143. Noven Pharmaceuticals, Inc. Passive Transdermal Drug Delivery Product Offered
Table 144. Noven Pharmaceuticals, Inc. Passive Transdermal Drug Delivery Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 145. Noven Pharmaceuticals, Inc. Main Business
Table 146. Noven Pharmaceuticals, Inc. Latest Developments
Table 147. Transdermal Corp. Basic Information, Passive Transdermal Drug Delivery Manufacturing Base, Sales Area and Its Competitors
Table 148. Transdermal Corp. Passive Transdermal Drug Delivery Product Offered
Table 149. Transdermal Corp. Passive Transdermal Drug Delivery Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 150. Transdermal Corp. Main Business
Table 151. Transdermal Corp. Latest Developments
Table 1. Passive Transdermal Drug Delivery Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Passive Transdermal Drug Delivery Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Microfluidics
Table 4. Major Players of Smart Pill Technology (SPT)
Table 5. Global Passive Transdermal Drug Delivery Sales by Type (2017-2022) & (K Units)
Table 6. Global Passive Transdermal Drug Delivery Sales Market Share by Type (2017-2022)
Table 7. Global Passive Transdermal Drug Delivery Revenue by Type (2017-2022) & ($ million)
Table 8. Global Passive Transdermal Drug Delivery Revenue Market Share by Type (2017-2022)
Table 9. Global Passive Transdermal Drug Delivery Sale Price by Type (2017-2022) & (USD/Unit)
Table 10. Global Passive Transdermal Drug Delivery Sales by Application (2017-2022) & (K Units)
Table 11. Global Passive Transdermal Drug Delivery Sales Market Share by Application (2017-2022)
Table 12. Global Passive Transdermal Drug Delivery Revenue by Application (2017-2022)
Table 13. Global Passive Transdermal Drug Delivery Revenue Market Share by Application (2017-2022)
Table 14. Global Passive Transdermal Drug Delivery Sale Price by Application (2017-2022) & (USD/Unit)
Table 15. Global Passive Transdermal Drug Delivery Sales by Company (2020-2022) & (K Units)
Table 16. Global Passive Transdermal Drug Delivery Sales Market Share by Company (2020-2022)
Table 17. Global Passive Transdermal Drug Delivery Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Passive Transdermal Drug Delivery Revenue Market Share by Company (2020-2022)
Table 19. Global Passive Transdermal Drug Delivery Sale Price by Company (2020-2022) & (USD/Unit)
Table 20. Key Manufacturers Passive Transdermal Drug Delivery Producing Area Distribution and Sales Area
Table 21. Players Passive Transdermal Drug Delivery Products Offered
Table 22. Passive Transdermal Drug Delivery Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Passive Transdermal Drug Delivery Sales by Geographic Region (2017-2022) & (K Units)
Table 26. Global Passive Transdermal Drug Delivery Sales Market Share Geographic Region (2017-2022)
Table 27. Global Passive Transdermal Drug Delivery Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Passive Transdermal Drug Delivery Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Passive Transdermal Drug Delivery Sales by Country/Region (2017-2022) & (K Units)
Table 30. Global Passive Transdermal Drug Delivery Sales Market Share by Country/Region (2017-2022)
Table 31. Global Passive Transdermal Drug Delivery Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Passive Transdermal Drug Delivery Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Passive Transdermal Drug Delivery Sales by Country (2017-2022) & (K Units)
Table 34. Americas Passive Transdermal Drug Delivery Sales Market Share by Country (2017-2022)
Table 35. Americas Passive Transdermal Drug Delivery Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Passive Transdermal Drug Delivery Revenue Market Share by Country (2017-2022)
Table 37. Americas Passive Transdermal Drug Delivery Sales by Type (2017-2022) & (K Units)
Table 38. Americas Passive Transdermal Drug Delivery Sales Market Share by Type (2017-2022)
Table 39. Americas Passive Transdermal Drug Delivery Sales by Application (2017-2022) & (K Units)
Table 40. Americas Passive Transdermal Drug Delivery Sales Market Share by Application (2017-2022)
Table 41. APAC Passive Transdermal Drug Delivery Sales by Region (2017-2022) & (K Units)
Table 42. APAC Passive Transdermal Drug Delivery Sales Market Share by Region (2017-2022)
Table 43. APAC Passive Transdermal Drug Delivery Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Passive Transdermal Drug Delivery Revenue Market Share by Region (2017-2022)
Table 45. APAC Passive Transdermal Drug Delivery Sales by Type (2017-2022) & (K Units)
Table 46. APAC Passive Transdermal Drug Delivery Sales Market Share by Type (2017-2022)
Table 47. APAC Passive Transdermal Drug Delivery Sales by Application (2017-2022) & (K Units)
Table 48. APAC Passive Transdermal Drug Delivery Sales Market Share by Application (2017-2022)
Table 49. Europe Passive Transdermal Drug Delivery Sales by Country (2017-2022) & (K Units)
Table 50. Europe Passive Transdermal Drug Delivery Sales Market Share by Country (2017-2022)
Table 51. Europe Passive Transdermal Drug Delivery Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Passive Transdermal Drug Delivery Revenue Market Share by Country (2017-2022)
Table 53. Europe Passive Transdermal Drug Delivery Sales by Type (2017-2022) & (K Units)
Table 54. Europe Passive Transdermal Drug Delivery Sales Market Share by Type (2017-2022)
Table 55. Europe Passive Transdermal Drug Delivery Sales by Application (2017-2022) & (K Units)
Table 56. Europe Passive Transdermal Drug Delivery Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Passive Transdermal Drug Delivery Sales by Country (2017-2022) & (K Units)
Table 58. Middle East & Africa Passive Transdermal Drug Delivery Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Passive Transdermal Drug Delivery Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Passive Transdermal Drug Delivery Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Passive Transdermal Drug Delivery Sales by Type (2017-2022) & (K Units)
Table 62. Middle East & Africa Passive Transdermal Drug Delivery Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Passive Transdermal Drug Delivery Sales by Application (2017-2022) & (K Units)
Table 64. Middle East & Africa Passive Transdermal Drug Delivery Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Passive Transdermal Drug Delivery
Table 66. Key Market Challenges & Risks of Passive Transdermal Drug Delivery
Table 67. Key Industry Trends of Passive Transdermal Drug Delivery
Table 68. Passive Transdermal Drug Delivery Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Passive Transdermal Drug Delivery Distributors List
Table 71. Passive Transdermal Drug Delivery Customer List
Table 72. Global Passive Transdermal Drug Delivery Sales Forecast by Region (2023-2028) & (K Units)
Table 73. Global Passive Transdermal Drug Delivery Sales Market Forecast by Region
Table 74. Global Passive Transdermal Drug Delivery Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Passive Transdermal Drug Delivery Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Passive Transdermal Drug Delivery Sales Forecast by Country (2023-2028) & (K Units)
Table 77. Americas Passive Transdermal Drug Delivery Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Passive Transdermal Drug Delivery Sales Forecast by Region (2023-2028) & (K Units)
Table 79. APAC Passive Transdermal Drug Delivery Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Passive Transdermal Drug Delivery Sales Forecast by Country (2023-2028) & (K Units)
Table 81. Europe Passive Transdermal Drug Delivery Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Passive Transdermal Drug Delivery Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Middle East & Africa Passive Transdermal Drug Delivery Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Passive Transdermal Drug Delivery Sales Forecast by Type (2023-2028) & (K Units)
Table 85. Global Passive Transdermal Drug Delivery Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Passive Transdermal Drug Delivery Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Passive Transdermal Drug Delivery Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Passive Transdermal Drug Delivery Sales Forecast by Application (2023-2028) & (K Units)
Table 89. Global Passive Transdermal Drug Delivery Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Passive Transdermal Drug Delivery Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Passive Transdermal Drug Delivery Revenue Market Share Forecast by Application (2023-2028)
Table 92. 3M Basic Information, Passive Transdermal Drug Delivery Manufacturing Base, Sales Area and Its Competitors
Table 93. 3M Passive Transdermal Drug Delivery Product Offered
Table 94. 3M Passive Transdermal Drug Delivery Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 95. 3M Main Business
Table 96. 3M Latest Developments
Table 97. Actavis, Inc. Basic Information, Passive Transdermal Drug Delivery Manufacturing Base, Sales Area and Its Competitors
Table 98. Actavis, Inc. Passive Transdermal Drug Delivery Product Offered
Table 99. Actavis, Inc. Passive Transdermal Drug Delivery Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 100. Actavis, Inc. Main Business
Table 101. Actavis, Inc. Latest Developments
Table 102. Bayer AG Basic Information, Passive Transdermal Drug Delivery Manufacturing Base, Sales Area and Its Competitors
Table 103. Bayer AG Passive Transdermal Drug Delivery Product Offered
Table 104. Bayer AG Passive Transdermal Drug Delivery Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 105. Bayer AG Main Business
Table 106. Bayer AG Latest Developments
Table 107. Boehringer Ingelheim GmbH Basic Information, Passive Transdermal Drug Delivery Manufacturing Base, Sales Area and Its Competitors
Table 108. Boehringer Ingelheim GmbH Passive Transdermal Drug Delivery Product Offered
Table 109. Boehringer Ingelheim GmbH Passive Transdermal Drug Delivery Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 110. Boehringer Ingelheim GmbH Main Business
Table 111. Boehringer Ingelheim GmbH Latest Developments
Table 112. Corium International, Inc. Basic Information, Passive Transdermal Drug Delivery Manufacturing Base, Sales Area and Its Competitors
Table 113. Corium International, Inc. Passive Transdermal Drug Delivery Product Offered
Table 114. Corium International, Inc. Passive Transdermal Drug Delivery Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 115. Corium International, Inc. Main Business
Table 116. Corium International, Inc. Latest Developments
Table 117. Echo Therapeutics, Inc. Basic Information, Passive Transdermal Drug Delivery Manufacturing Base, Sales Area and Its Competitors
Table 118. Echo Therapeutics, Inc. Passive Transdermal Drug Delivery Product Offered
Table 119. Echo Therapeutics, Inc. Passive Transdermal Drug Delivery Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 120. Echo Therapeutics, Inc. Main Business
Table 121. Echo Therapeutics, Inc. Latest Developments
Table 122. GlaxoSmithKline plc Basic Information, Passive Transdermal Drug Delivery Manufacturing Base, Sales Area and Its Competitors
Table 123. GlaxoSmithKline plc Passive Transdermal Drug Delivery Product Offered
Table 124. GlaxoSmithKline plc Passive Transdermal Drug Delivery Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 125. GlaxoSmithKline plc Main Business
Table 126. GlaxoSmithKline plc Latest Developments
Table 127. Johnson & Johnson (Janssen Pharmaceuticals Inc.) Basic Information, Passive Transdermal Drug Delivery Manufacturing Base, Sales Area and Its Competitors
Table 128. Johnson & Johnson (Janssen Pharmaceuticals Inc.) Passive Transdermal Drug Delivery Product Offered
Table 129. Johnson & Johnson (Janssen Pharmaceuticals Inc.) Passive Transdermal Drug Delivery Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 130. Johnson & Johnson (Janssen Pharmaceuticals Inc.) Main Business
Table 131. Johnson & Johnson (Janssen Pharmaceuticals Inc.) Latest Developments
Table 132. Mylan N.V. Basic Information, Passive Transdermal Drug Delivery Manufacturing Base, Sales Area and Its Competitors
Table 133. Mylan N.V. Passive Transdermal Drug Delivery Product Offered
Table 134. Mylan N.V. Passive Transdermal Drug Delivery Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 135. Mylan N.V. Main Business
Table 136. Mylan N.V. Latest Developments
Table 137. Novartis AG Basic Information, Passive Transdermal Drug Delivery Manufacturing Base, Sales Area and Its Competitors
Table 138. Novartis AG Passive Transdermal Drug Delivery Product Offered
Table 139. Novartis AG Passive Transdermal Drug Delivery Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 140. Novartis AG Main Business
Table 141. Novartis AG Latest Developments
Table 142. Noven Pharmaceuticals, Inc. Basic Information, Passive Transdermal Drug Delivery Manufacturing Base, Sales Area and Its Competitors
Table 143. Noven Pharmaceuticals, Inc. Passive Transdermal Drug Delivery Product Offered
Table 144. Noven Pharmaceuticals, Inc. Passive Transdermal Drug Delivery Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 145. Noven Pharmaceuticals, Inc. Main Business
Table 146. Noven Pharmaceuticals, Inc. Latest Developments
Table 147. Transdermal Corp. Basic Information, Passive Transdermal Drug Delivery Manufacturing Base, Sales Area and Its Competitors
Table 148. Transdermal Corp. Passive Transdermal Drug Delivery Product Offered
Table 149. Transdermal Corp. Passive Transdermal Drug Delivery Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 150. Transdermal Corp. Main Business
Table 151. Transdermal Corp. Latest Developments
LIST OF FIGURES
Figure 1. Picture of Passive Transdermal Drug Delivery
Figure 2. Passive Transdermal Drug Delivery Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Passive Transdermal Drug Delivery Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Passive Transdermal Drug Delivery Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Passive Transdermal Drug Delivery Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Microfluidics
Figure 10. Product Picture of Smart Pill Technology (SPT)
Figure 11. Global Passive Transdermal Drug Delivery Sales Market Share by Type in 2021
Figure 12. Global Passive Transdermal Drug Delivery Revenue Market Share by Type (2017-2022)
Figure 13. Passive Transdermal Drug Delivery Consumed in Clinic
Figure 14. Global Passive Transdermal Drug Delivery Market: Clinic (2017-2022) & (K Units)
Figure 15. Passive Transdermal Drug Delivery Consumed in Hospital
Figure 16. Global Passive Transdermal Drug Delivery Market: Hospital (2017-2022) & (K Units)
Figure 17. Passive Transdermal Drug Delivery Consumed in Others
Figure 18. Global Passive Transdermal Drug Delivery Market: Others (2017-2022) & (K Units)
Figure 19. Global Passive Transdermal Drug Delivery Sales Market Share by Application (2017-2022)
Figure 20. Global Passive Transdermal Drug Delivery Revenue Market Share by Application in 2021
Figure 21. Passive Transdermal Drug Delivery Revenue Market by Company in 2021 ($ Million)
Figure 22. Global Passive Transdermal Drug Delivery Revenue Market Share by Company in 2021
Figure 23. Global Passive Transdermal Drug Delivery Sales Market Share by Geographic Region (2017-2022)
Figure 24. Global Passive Transdermal Drug Delivery Revenue Market Share by Geographic Region in 2021
Figure 25. Global Passive Transdermal Drug Delivery Sales Market Share by Region (2017-2022)
Figure 26. Global Passive Transdermal Drug Delivery Revenue Market Share by Country/Region in 2021
Figure 27. Americas Passive Transdermal Drug Delivery Sales 2017-2022 (K Units)
Figure 28. Americas Passive Transdermal Drug Delivery Revenue 2017-2022 ($ Millions)
Figure 29. APAC Passive Transdermal Drug Delivery Sales 2017-2022 (K Units)
Figure 30. APAC Passive Transdermal Drug Delivery Revenue 2017-2022 ($ Millions)
Figure 31. Europe Passive Transdermal Drug Delivery Sales 2017-2022 (K Units)
Figure 32. Europe Passive Transdermal Drug Delivery Revenue 2017-2022 ($ Millions)
Figure 33. Middle East & Africa Passive Transdermal Drug Delivery Sales 2017-2022 (K Units)
Figure 34. Middle East & Africa Passive Transdermal Drug Delivery Revenue 2017-2022 ($ Millions)
Figure 35. Americas Passive Transdermal Drug Delivery Sales Market Share by Country in 2021
Figure 36. Americas Passive Transdermal Drug Delivery Revenue Market Share by Country in 2021
Figure 37. United States Passive Transdermal Drug Delivery Revenue Growth 2017-2022 ($ Millions)
Figure 38. Canada Passive Transdermal Drug Delivery Revenue Growth 2017-2022 ($ Millions)
Figure 39. Mexico Passive Transdermal Drug Delivery Revenue Growth 2017-2022 ($ Millions)
Figure 40. Brazil Passive Transdermal Drug Delivery Revenue Growth 2017-2022 ($ Millions)
Figure 41. APAC Passive Transdermal Drug Delivery Sales Market Share by Region in 2021
Figure 42. APAC Passive Transdermal Drug Delivery Revenue Market Share by Regions in 2021
Figure 43. China Passive Transdermal Drug Delivery Revenue Growth 2017-2022 ($ Millions)
Figure 44. Japan Passive Transdermal Drug Delivery Revenue Growth 2017-2022 ($ Millions)
Figure 45. South Korea Passive Transdermal Drug Delivery Revenue Growth 2017-2022 ($ Millions)
Figure 46. Southeast Asia Passive Transdermal Drug Delivery Revenue Growth 2017-2022 ($ Millions)
Figure 47. India Passive Transdermal Drug Delivery Revenue Growth 2017-2022 ($ Millions)
Figure 48. Australia Passive Transdermal Drug Delivery Revenue Growth 2017-2022 ($ Millions)
Figure 49. Europe Passive Transdermal Drug Delivery Sales Market Share by Country in 2021
Figure 50. Europe Passive Transdermal Drug Delivery Revenue Market Share by Country in 2021
Figure 51. Germany Passive Transdermal Drug Delivery Revenue Growth 2017-2022 ($ Millions)
Figure 52. France Passive Transdermal Drug Delivery Revenue Growth 2017-2022 ($ Millions)
Figure 53. UK Passive Transdermal Drug Delivery Revenue Growth 2017-2022 ($ Millions)
Figure 54. Italy Passive Transdermal Drug Delivery Revenue Growth 2017-2022 ($ Millions)
Figure 55. Russia Passive Transdermal Drug Delivery Revenue Growth 2017-2022 ($ Millions)
Figure 56. Middle East & Africa Passive Transdermal Drug Delivery Sales Market Share by Country in 2021
Figure 57. Middle East & Africa Passive Transdermal Drug Delivery Revenue Market Share by Country in 2021
Figure 58. Egypt Passive Transdermal Drug Delivery Revenue Growth 2017-2022 ($ Millions)
Figure 59. South Africa Passive Transdermal Drug Delivery Revenue Growth 2017-2022 ($ Millions)
Figure 60. Israel Passive Transdermal Drug Delivery Revenue Growth 2017-2022 ($ Millions)
Figure 61. Turkey Passive Transdermal Drug Delivery Revenue Growth 2017-2022 ($ Millions)
Figure 62. GCC Country Passive Transdermal Drug Delivery Revenue Growth 2017-2022 ($ Millions)
Figure 63. Manufacturing Cost Structure Analysis of Passive Transdermal Drug Delivery in 2021
Figure 64. Manufacturing Process Analysis of Passive Transdermal Drug Delivery
Figure 65. Industry Chain Structure of Passive Transdermal Drug Delivery
Figure 66. Channels of Distribution
Figure 67. Distributors Profiles
Figure 1. Picture of Passive Transdermal Drug Delivery
Figure 2. Passive Transdermal Drug Delivery Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Passive Transdermal Drug Delivery Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Passive Transdermal Drug Delivery Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Passive Transdermal Drug Delivery Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Microfluidics
Figure 10. Product Picture of Smart Pill Technology (SPT)
Figure 11. Global Passive Transdermal Drug Delivery Sales Market Share by Type in 2021
Figure 12. Global Passive Transdermal Drug Delivery Revenue Market Share by Type (2017-2022)
Figure 13. Passive Transdermal Drug Delivery Consumed in Clinic
Figure 14. Global Passive Transdermal Drug Delivery Market: Clinic (2017-2022) & (K Units)
Figure 15. Passive Transdermal Drug Delivery Consumed in Hospital
Figure 16. Global Passive Transdermal Drug Delivery Market: Hospital (2017-2022) & (K Units)
Figure 17. Passive Transdermal Drug Delivery Consumed in Others
Figure 18. Global Passive Transdermal Drug Delivery Market: Others (2017-2022) & (K Units)
Figure 19. Global Passive Transdermal Drug Delivery Sales Market Share by Application (2017-2022)
Figure 20. Global Passive Transdermal Drug Delivery Revenue Market Share by Application in 2021
Figure 21. Passive Transdermal Drug Delivery Revenue Market by Company in 2021 ($ Million)
Figure 22. Global Passive Transdermal Drug Delivery Revenue Market Share by Company in 2021
Figure 23. Global Passive Transdermal Drug Delivery Sales Market Share by Geographic Region (2017-2022)
Figure 24. Global Passive Transdermal Drug Delivery Revenue Market Share by Geographic Region in 2021
Figure 25. Global Passive Transdermal Drug Delivery Sales Market Share by Region (2017-2022)
Figure 26. Global Passive Transdermal Drug Delivery Revenue Market Share by Country/Region in 2021
Figure 27. Americas Passive Transdermal Drug Delivery Sales 2017-2022 (K Units)
Figure 28. Americas Passive Transdermal Drug Delivery Revenue 2017-2022 ($ Millions)
Figure 29. APAC Passive Transdermal Drug Delivery Sales 2017-2022 (K Units)
Figure 30. APAC Passive Transdermal Drug Delivery Revenue 2017-2022 ($ Millions)
Figure 31. Europe Passive Transdermal Drug Delivery Sales 2017-2022 (K Units)
Figure 32. Europe Passive Transdermal Drug Delivery Revenue 2017-2022 ($ Millions)
Figure 33. Middle East & Africa Passive Transdermal Drug Delivery Sales 2017-2022 (K Units)
Figure 34. Middle East & Africa Passive Transdermal Drug Delivery Revenue 2017-2022 ($ Millions)
Figure 35. Americas Passive Transdermal Drug Delivery Sales Market Share by Country in 2021
Figure 36. Americas Passive Transdermal Drug Delivery Revenue Market Share by Country in 2021
Figure 37. United States Passive Transdermal Drug Delivery Revenue Growth 2017-2022 ($ Millions)
Figure 38. Canada Passive Transdermal Drug Delivery Revenue Growth 2017-2022 ($ Millions)
Figure 39. Mexico Passive Transdermal Drug Delivery Revenue Growth 2017-2022 ($ Millions)
Figure 40. Brazil Passive Transdermal Drug Delivery Revenue Growth 2017-2022 ($ Millions)
Figure 41. APAC Passive Transdermal Drug Delivery Sales Market Share by Region in 2021
Figure 42. APAC Passive Transdermal Drug Delivery Revenue Market Share by Regions in 2021
Figure 43. China Passive Transdermal Drug Delivery Revenue Growth 2017-2022 ($ Millions)
Figure 44. Japan Passive Transdermal Drug Delivery Revenue Growth 2017-2022 ($ Millions)
Figure 45. South Korea Passive Transdermal Drug Delivery Revenue Growth 2017-2022 ($ Millions)
Figure 46. Southeast Asia Passive Transdermal Drug Delivery Revenue Growth 2017-2022 ($ Millions)
Figure 47. India Passive Transdermal Drug Delivery Revenue Growth 2017-2022 ($ Millions)
Figure 48. Australia Passive Transdermal Drug Delivery Revenue Growth 2017-2022 ($ Millions)
Figure 49. Europe Passive Transdermal Drug Delivery Sales Market Share by Country in 2021
Figure 50. Europe Passive Transdermal Drug Delivery Revenue Market Share by Country in 2021
Figure 51. Germany Passive Transdermal Drug Delivery Revenue Growth 2017-2022 ($ Millions)
Figure 52. France Passive Transdermal Drug Delivery Revenue Growth 2017-2022 ($ Millions)
Figure 53. UK Passive Transdermal Drug Delivery Revenue Growth 2017-2022 ($ Millions)
Figure 54. Italy Passive Transdermal Drug Delivery Revenue Growth 2017-2022 ($ Millions)
Figure 55. Russia Passive Transdermal Drug Delivery Revenue Growth 2017-2022 ($ Millions)
Figure 56. Middle East & Africa Passive Transdermal Drug Delivery Sales Market Share by Country in 2021
Figure 57. Middle East & Africa Passive Transdermal Drug Delivery Revenue Market Share by Country in 2021
Figure 58. Egypt Passive Transdermal Drug Delivery Revenue Growth 2017-2022 ($ Millions)
Figure 59. South Africa Passive Transdermal Drug Delivery Revenue Growth 2017-2022 ($ Millions)
Figure 60. Israel Passive Transdermal Drug Delivery Revenue Growth 2017-2022 ($ Millions)
Figure 61. Turkey Passive Transdermal Drug Delivery Revenue Growth 2017-2022 ($ Millions)
Figure 62. GCC Country Passive Transdermal Drug Delivery Revenue Growth 2017-2022 ($ Millions)
Figure 63. Manufacturing Cost Structure Analysis of Passive Transdermal Drug Delivery in 2021
Figure 64. Manufacturing Process Analysis of Passive Transdermal Drug Delivery
Figure 65. Industry Chain Structure of Passive Transdermal Drug Delivery
Figure 66. Channels of Distribution
Figure 67. Distributors Profiles
